 should lead to an
evaluation for secondary causes of severe hypertension,
including the use of legal and illicit sympathomimetic
drugs, especially in patients with syndromic and nonsyndromic genetic defects predisposing to aortic disease.
Patients with an inﬂammatory vasculitis, such as
Takayasu disease, giant cell arteritis, and Behçet arteritis,
should also be considered at high risk for development
of TAA. The history should also